Cited by 119Garlic and Onion StudiesNatural Antidiabetic Agents StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: The results of double-blinded placebo-controlled study

Sobenin, Igor A., Nedosugova, Lyudmila V., Filatova, Lyudmila V., Balabolkin, Mikhail I., Gorchakova, Tatiana V., Orekhov, Alexander N.·2008·Acta Diabetologica

Abstract

Late complications in type 2 diabetic patients are commonly associated with accelerated development of atherosclerosis. In type 2 diabetes mellitus, non-enzymatic glycosylation of apo-B that is a function of hyperglycaemia is an efficient biochemical way of low-density lipoprotein atherogenic modification. So, proper metabolic control is needed to prevent late complications of diabetes. The study was performed to estimate the effects of time-released garlic powder tablet Allicor on the parameters of metabolic control and plasma lipids in type 2 diabetes mellitus. The metabolic action of Allicor was investigated in the 4-week double-blinded placebo-controlled study in 60 type 2 diabetic patients. Fasting blood glucose was measured daily, and serum fructosamine as well as cholesterol and triglyceride levels were determined at the baseline, after 1, 2, 3 and 4 weeks. It has been demonstrated that treatment with Allicor resulted in better metabolic control due to the lowering of fasting blood glucose, serum fructosamine and serum triglyceride levels. The results of this study may allow recommending garlic powder tablets Allicor for the treatment of type 2 diabetes mellitus along with dietary treatment and/or sulfonylurea derivatives to achieve better metabolic control. The benefits from garlic preparations may lead to the reduction of cardiovascular risk in diabetic patients.

Integrity signals

Registry

Crossref · 10.1007/s00592-007-0011-x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Garlic administration at a dose of 300 and 60 mg/day for 12 months and 12 weeks, respectively, decreased total cholesterol, triglyceride, and LDL while increased HDL in patients.

    “Sobenin et al. [110,111] revealed that garlic administration at a dose of 300 and 60 mg/day for 12 months and 12 weeks, respectively decreased TC, TG, and LDL while increased HDL.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sobenin, I. A., Nedosugova, L. V., Filatova, L. V., Balabolkin, M. I., Gorchakova, T. V., & Orekhov, A. N.
Affiliations
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
Venue
Acta Diabetologica
Published
2007-09-06
Volume
45
Issue
1
Pages
1-6
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W2097385227
Cited by
119
References
51
Citations by year
2026: 5 · 2025: 7 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 11 · 2019: 11 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 4 · 2013: 12 · 2012: 6
FWCI
2.43
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Diabetologica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Garlic and Onion Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, metabolic control, fasting blood glucose, serum fructosamine, serum triglycerides, serum cholesterol, glycation, atherosclerosis, cardiovascular risk, sulfonylurea derivatives
MeSH terms
Adult, Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Garlic, Humans, Lipids, Male, Middle Aged, Placebos, Powders, Tablets, Fructosamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review